AFC-HD AMS Life Science Co., Ltd. (2927.T)
- Previous Close
846.00 - Open
846.00 - Bid 842.00 x --
- Ask 846.00 x --
- Day's Range
838.00 - 846.00 - 52 Week Range
753.00 - 968.00 - Volume
27,800 - Avg. Volume
66,150 - Market Cap (intraday)
11.891B - Beta (5Y Monthly) 0.39
- PE Ratio (TTM)
8.93 - EPS (TTM)
94.75 - Earnings Date Jul 12, 2024 - Jul 16, 2024
- Forward Dividend & Yield 30.00 (3.55%)
- Ex-Dividend Date Aug 29, 2024
- 1y Target Est
--
AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs, and publishing health information magazines. The Pharmaceutical segment manufactures and sells Chinese herbal medicine, over-the-counter medicines, and generic medicines. The Department Store segment engages in the wholesale of watches, jewelry, and precious metal products. The Food and Beverage segment operates restaurants. The Other Business segment engages in the real estate buying, selling, management, rental, and intermediary business; construction industry; tourism, travel and hotel industry; and school lunch business. AFC-HD AMS Life Science Co., Ltd. was founded in 1969 and is headquartered in Shizuoka, Japan.
www.ams-life.com878
Full Time Employees
August 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 2927.T
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2927.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2927.T
Valuation Measures
Market Cap
11.89B
Enterprise Value
23.34B
Trailing P/E
8.93
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.43
Price/Book (mrq)
0.87
Enterprise Value/Revenue
0.84
Enterprise Value/EBITDA
7.61
Financial Highlights
Profitability and Income Statement
Profit Margin
4.80%
Return on Assets (ttm)
2.97%
Return on Equity (ttm)
10.13%
Revenue (ttm)
27.68B
Net Income Avi to Common (ttm)
1.33B
Diluted EPS (ttm)
94.75
Balance Sheet and Cash Flow
Total Cash (mrq)
10.3B
Total Debt/Equity (mrq)
159.63%
Levered Free Cash Flow (ttm)
-3.04B
Company Insights: 2927.T
2927.T does not have Company Insights